Form 4: Accenture Director Receives Anti-Dilution RSU Grant
Insider Transaction Report
Accenture plc Director Masahiko Uotani received 5 Class A ordinary shares as a grant of Restricted Share Units due to anti-dilution provisions following a cash dividend.
Summary
- Accenture plc Director Masahiko Uotani acquired 5 Class A ordinary shares.
- The acquisition occurred on November 14, 2025.
- These shares were granted as Restricted Share Units (RSUs) at a price of $0.
- The grant was made pursuant to anti-dilution provisions of previously awarded RSUs, reflecting Accenture plc's payment of a cash dividend.
- Following this transaction, Masahiko Uotani directly beneficially owns 624 Class A ordinary shares.
Sentiment
Score: 5
Explanation: The transaction is a routine, non-cash grant of shares to a director as an anti-dilution adjustment, which is neutral for the company's operational performance but reflects standard equity compensation practices.
Positives
- The grant of RSUs to Director Masahiko Uotani reflects a routine adjustment to maintain the value of his existing RSU awards following a cash dividend, indicating sound corporate governance regarding equity compensation.
Future Outlook
NA
Industry Context
This is a routine insider transaction (Form 4) reporting a grant of Restricted Share Units (RSUs) to a director. Such grants are common practice in public companies for executive and director compensation, often including anti-dilution provisions to protect the value of equity awards during corporate actions like dividend payments. It does not provide broader industry trends or competitive insights.
Stakeholder Impact
- Shareholders: Minimal direct impact as it's a small, routine anti-dilution adjustment to existing equity compensation.
- Director (Masahiko Uotani): The grant ensures the value of previously awarded RSUs is maintained, which is positive for the director's compensation.
Key Dates
| Date | Description |
|---|---|
| 11/14/2025 | Date of transaction where 5 Class A ordinary shares were acquired. |
| 11/18/2025 | Date the Form 4 was signed by the attorney-in-fact for Masahiko Uotani. |
Keywords
Accenture, ACN, Form 4, Insider Transaction, Restricted Share Units, RSU Grant, Anti-Dilution, Director Compensation, Masahiko Uotani
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.